News & Events

  • May 11, 2017

    Client Alert: New York City Bans All Inquiries Regarding Salary Histories of Job Applicants

    New York City has joined other states and cities across the country – including Massachusetts and Philadelphia – in banning employers from inquiring about a job candidate’s salary history. Per legislation signed on May 4, 2017 by New York City Mayor Bill DeBlasio, effective November 1, 2017, all employers in New York City, both public and private and regardless of size, may no longer:

    (1)        inquire about the salary history of an applicant for employment; or
    (2)        rely on the salary history of an applicant in determining that applicant’s salary at any stage in the employment process, unless the applicant “unprompted” and “willingly” discloses his or her prior salary information.

    Click here to read the alert.

  • May 03, 2017

    On April 26, 2017, the Appellate Division, Second Department issued a decision reversing the Surrogate of Rockland County who had previously granted petitioner’s motion for summary judgment against EGS client, Alfred Zucaro.  In reversing, the Second Department also granted Mr. Zucaro summary judgment dismissing petitioner’s conversion cause of action against him.

    James K. Landau, a member of the Firm, represented Mr. Zucaro in connection with the appeal.  A copy of the decision can be found at http://law.justia.com/cases/new-york/appellate-division-second-department/2017/2015-02684.html.

  • May 01, 2017

    The Deal issued its quarterly PIPE league tables, revealing that 2017's first quarter outperformed last year's first quarter. Deals were up nearly 75% from the previous year to 367, while dollars raised were up almost 70% to $21.3 billion.

    EG&S is top ranked.  Click here to read the article.

  • April 17, 2017

    Cytori Therapeutics announced the closing of a confidentially marketed public offering of common stock in the amount of $8.8 million.  EG&S acted as counsel to the underwriter, Maxim Group LLC.

  • April 12, 2017

    Forum Merger Corporation, a company formed for the purpose of entering into a merger, share exchange, asset acquisition or other similar business combination with one or more businesses or entities, announced the closing of its initial public offering in the amount of $150,000,000.  EG&S acted as counsel to Forum Merger.

  • April 12, 2017

    Blink Health announced that it has raised a $90 million Series B equity funding led by 8VC, bringing its total venture capital funding to $165 million. Blink Health is a technology platform that enables consumers to access the medications at affordable prices through over 57,000 pharmacies nationwide.  EGS acted as counsel to Blink Health.

  • April 04, 2017

    ITUS Corporation announced the closing of its rights offering of common shares in the amount of $4,700,000.  EG&S acted as counsel to ITUS.

  • March 31, 2017

    Douglas S. Ellenoff, a member of the Firm, wrote an article for LexisNexis; Lexis Practice Advisor titled "Market Trends: Crowdfunding."  

    Click here to read the article

  • March 30, 2017

    Kayne Anderson Acquisition Corp. announced the closing of its initial public offering in the amount of $350,000,000. EG&S acted as counsel to Kayne Anderson.

  • March 24, 2017

    Delaware Court of Chancery granting summary judgment to EG&S client, Shu Kaneko, freeing him from liability on all the claims brought against him by the receiver for Southern China Livestock International, Inc. (SCLI). The Receiver brought claims against Mr. Kaneko seeking approximately $8M in damages, despite SCLI having given Mr. Kaneko a full release as part of a settlement agreement in February 2013, sixteen months before the Receiver first filed suit.  EG&S acted as counel to Mr. Kaneko.  J.B. Horgan, an Associate of the Firm, was on this case from the beginning, having written the summary judgment brief and argued it before the Chancery Court.

  • March 16, 2017

    Amanda M. Fugazy, a member of the Firm, will be speaking at NGO's symposium "Fraud & Corruption: Mitigating a Top NGO Risk". Her topic is "Hiring & Vetting: How Well Are You Checking?.  View her presentation here.

    Click here for more info

  • March 15, 2017

    Matlin & Partners Acquisition Co. announced the closing of their initial public offering in the amount of $325,000,000.  EG&S acted as counsel to Matlin.

  • March 10, 2017

    EG&S LLP 2016 Year End Summary

    2016 was another year of significant events and milestones for Ellenoff Grossman & Schole LLP.   We continued to grow our areas of practice, strengthening our existing lines of business and have the privilege of participating in ever increasing matters of complexity. 

    Click here to read more

  • March 09, 2017

    Kayne Anderson Capital Advisors LP announced their plans for an initial public offering that would raise $350 million for a special purpose acquisition company, or “blank-check company,” with its sights on acquiring an energy business.  EG&S is counsel to Kayne.

  • March 02, 2017

    James K. Landau, a member of the Firm, was invited by PLI to participate on a panel discussing the use of social media by attorneys on March 17, 2017.

    Click here for more details

  • February 27, 2017

    Daseke, Inc. and Hennessy Capital Acquisition Corp. II announced the completion of their business combination.  EG&S acted as special SPAC counsel to Hennessy.

  • February 21, 2017

    Ellenoff Grossman & Schole LLP is proud to announce the addition of a new practice group – Immigration.  John Assadi joins EG&S as a Member and Mauricio Martinez as an Associate.

    Click here to view the announcement

  • February 07, 2017

    Ellenoff Grossman & Schole LLP is proud to announce the addition of a new attorney in our Corporate department.  His name is Jeffrey W. Rubin and he joins as a member of the Firm and specializes in corporate, M&A and securities law.

    Click here to read his announcement

  • January 31, 2017

    The Ninth Circuit has dismissed an appeal by a group of shareholders who had accused Cellular Biomedicine Group in a federal class action of inflating its stock price through a promotional scheme.  Plaintiffs chose not to challenge the district court's holding that they could not allege loss causation.

    Adrienne M. Ward and Michael J. Sullivan, both members of the Firm, represented Cellular Biomedicine in the appeal.  Click here to read more on the case.

  • January 30, 2017

    The February 2017 edition of Westchester Lawyer Magazine includes an article by James K. Landau, a member in the Firm’s litigation department, entitled “How to Leverage the Internet and Technology to Sharpen your Appellate Advocacy”.  Mr. Landau is the co-chair of the Westchester County Bar Association’s Committee on Appellate Practice and handles cases involving misappropriation of trade secrets, non-competition clauses in employment agreements and real estate related litigation.  The article can be read here.

  • January 27, 2017

    BioAmber Inc. announced the closing of their Underwritten offering in the amount of $20,125,009.  EG&S acted as counsel to the Underwriter.

  • January 25, 2017

    Fintech Acquisition Corp. II announced the closing of their initial public offering in the amount of $153,000,000.  EG&S acted as counsel to Cantor Fitzgerald.

  • January 24, 2017

    Amedica Corporation announced the closing of their Confidentially Marketed Public Offering in the amount of $4,500,000.  EG&S acted as counsel to Maxim Group.

  • January 24, 2017

    EGS assisted PhotoMedex, Inc. in its sale of substantially all of its assets primarily related to or used in the company’s consumer products division, including its no!no!® hair and skin products and the Kyrobak back pain management products.

    The gross proceeds receivable by the company were up to $5M. In addition, the company entered into a royalty agreement with the purchaser.

  • January 24, 2017

    Can-Fite Biopharma Ltd. announced the closing of their Registered Direct offering in the amount of $5,000,000.  EG&S acted as counsel to the Placement Agent.